This event has passed.

Advances in Cardiology – Interventional Technology in 2022

Name: Advances in Cardiology – Interventional Technology in 2022
Start: 2022-04-27T16:30:00-04:00
End: 2022-04-27T18:30:00-04:00
Location: Online

April 27, 2022 @ 4:30 pm - 6:30 pm EDT

Free

Recordings

Full Length

Highlights Preview

Abstract

Heart disease remains the number one killer of men and women in the US and globally. Unexpectedly, COVID-19 has emerged as a major new cause of cardiac damage. In this Forum, you will hear from leaders in interventional cardiology who are developing technologies to overcome challenges in treating cardiovascular patients. These include imaging, drug delivery, biomarkers for COVID-19 related clot formation, and structural heart disease. Hear and meet these leaders in CV disease diagnosis and treatment.

Mazen Albaghdadi, MD, MSc

Physician Innovation Fellow at Edwards Lifesciences

Dr. Albaghdadi is an accomplished physician-scientist with a background in engineering and pre-clinical testing, and device innovation. He has developed many cardiovascular technologies including intravascular imaging modalities, macro- and nano-drug delivery systems, biomarkers in COVID19-related thrombosis, and structural heart disease.

Stuart T. Higano, MD, FACC, FSCAI

Medical Director, Heart LifeLine Alliance, Missouri Baptist Medical Center, Saint Louis, Missouri

Dr. Higano is Medical Director of Heart LifeLine Alliance, formed in 2008 in partnership with rural hospitals, medical helicopter and ambulance services to provide emergency services for rapid evaluation and treatment of heart attack patients. He will speak about how new technologies are helping to overcome challenges in interventional cardiology.

Marty Sklar, MSME, BSME

Business Development, Electrophysiology Frontiers, Co-Founder of MDG Boston

Mr. Sklar is an accomplished leader, inventor, consultant and engineer. In 2013, he founded Ablacor Medical Corporation (now part of Electrophysiology Frontiers) to develop remote controlled instruments for minimally invasive medical applications. He was a co-founder and first president of MDG Boston.

Lisa Sasso, MBA, PCC, CPCC

Executive Coach & President, Medical Development Partners; Former President, MDG Boston MODERATOR

Ms. Sasso was President & CEO of Radi Medical Systems for 6 years. She grew revenue from $0 to $28M and was recognized and ranked #28 out of 100 Women Led Businesses in MA in 2004. She is President of Medical Development Partners and offers her experiences as an executive coach.

Geoff Moodie, PhD

Director, Biocompatibility, Eurofins; Board of Directors and VP of Programming for MDG Boston

Dr. Moodie a goal driven scientist with an expertise in absorbable materials and combination products for medical device and drug delivery applications. His experience includes preclinical study development, troubleshooting, and monitoring, as well as budgeting, timelines and resource allocation.

Hamsini Sundararaman

Biomedical Engineer; Event Organizer for Program Central, MDG Boston

Ms. Sundararaman is a recent graduate of Northeastern University with a Master’s Degree in Bioengineering with a specialization in medical device design and bio-imaging.